Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2020-04-03 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by a regulatory authority (Jilin Province Drug Administration). It details the registration certificates obtained for specific medical products and discusses the potential impact on the company's business. The document is short (1175 characters) and does not contain financial statements, detailed financial performance, or management discussion. It is an announcement of a regulatory approval event rather than a financial report or management update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-04-03 Chinese
关于变更经营范围暨修改《公司章程》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding changes to the business scope and amendments to the company's articles of association. It includes details about board resolutions and the need for shareholder approval. There are no financial statements, earnings data, or detailed report content. The document is relatively short (1732 characters) and serves as a formal announcement of corporate governance changes rather than a full report or detailed filing. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a proxy solicitation or voting results announcement. The content aligns best with a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate governance and business scope changes without detailed financial data or report content.
2020-04-03 Chinese
关于增加2020年第一次临时股东大会议案暨会议补充通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2020 first extraordinary general meeting (临时股东大会) of Dirui Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items for shareholder approval, and attachments such as proxy forms and registration forms. The agenda items focus on the issuance of convertible bonds, amendments to the company charter, and other corporate governance matters. The document is not a financial report, earnings release, or management discussion but rather a formal notice and supplementary information for a shareholder meeting. It is not merely a brief announcement of a report publication but a full notice with detailed meeting logistics and agenda. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and the agenda for voting, including proxy forms and voting instructions, it aligns best with Proxy Solicitation & Information Statement (PSI).
2020-04-03 Chinese
公司章程（2020年4月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 迪瑞医疗科技股份有限公司 (Dirui Medical Technology Co., Ltd.). It contains detailed sections on company governance, shareholder rights, board structure, share issuance, share transfer, shareholder meetings, and other corporate governance matters. It is a comprehensive internal governance document rather than a financial report, earnings release, or announcement. It does not contain financial statements or earnings data, nor is it a notice or announcement of a report. The content aligns with the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2020-04-03 Chinese
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management personnel (副总经理, vice general manager) at the company. It includes details about the appointment, the individual's background, and compliance with regulatory requirements. There is no financial data, no mention of financial results, or report publication. The content clearly fits the category of management or board changes. Therefore, the document is best classified as Board/Management Information (MANG). The document length is short and focused on personnel appointment, confirming this classification.
2020-04-02 Chinese
独立董事关于第四届董事会第四次临时会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the appointment of a senior management member at the company. It references compliance with company law and stock exchange rules, and it is signed by the independent directors. The content focuses on board/management personnel changes rather than financial results, audit, or other report types. The document length is short (730 characters), and it is not an announcement of a report publication but an opinion related to management appointments. Therefore, it fits best under Board/Management Information (MANG).
2020-04-02 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.